Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Use of arsenic trioxide in the treatment of acute promyelocytic leukemia (APL): I
Perceived determinants of children's inadequate sleep health
Together, these modifications reduce IGFBP binding affinity by approximately 100-fold while preserving full agonist activity at the type 1 IGF receptor (IGF-1R), creating a molecule with dramatically enhanced bioavailability in biological systems
Lancet Respiratory Med 9(3):239250 Chaumont H et al (2020) Acute meningoencephalitis in a patient with COVID-19
US$ 28.49
US$ 23.88
US$ 28.93
